Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Autoimmuuniintervention Mastery Course Study (AIM)

tiistai 15. syyskuuta 2026 päivittänyt: Terry L. Wahls

Arviointi verkkokurssista, joka on suunniteltu tukemaan terveellisemmän ruokavalion ja itsehoitorutiinien omaksumista multippeliskleroosipotilailla

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remission with persisting fatigue.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remissin with persisting fatigue. The cancer patients must be patients at the University of Iowa Holden Cancer Center.

Once eligibility criteria are determined and consent is obtained, participants would work through the course modules like a non-graded online course. There are exercises and personal assessments within the course participants are asked to take to build upon each other to increase the success of the experience while taking the course.

Throughout the course there will be modules that will discuss an inner game plan, food intervention plan, physical intervention plan, and an increased resilience plan. The fourth module suggests different strategies that participants can do to improve their health beyond food and exercise. These types of things would include supplements, light therapy, detoxification, improved sleep, stress reduction, and other ways to enhance their body's resilience.

Investigators ask that participants inform and work with their healthcare team to personalize their treatment and determine if the suggested strategies mentioned in the course are appropriate for their healthcare path. This will provide dietary education to a larger sample size compared to what has been studied in the past. The study may include more patients that have limited resources, including but not limited to, money and location for access to registered dietitians with expertise in dietary instruction for patient s diagnosed with multiple sclerosis and CIS. There is interest in education and support that can be delivered via an online platform that can lead to improved diet quality and self-care routines for multiple sclerosis and autoimmune patients.

This study will use a randomized single-blind wait list control design to evaluate the impact of an online course that teaches the modified Paleolithic diet, nutrient dense vegetarian diet and Mediterranean diets, stress reduction and exercise strategies using commercially available online course for autoimmune patients. Data will be collected in the short-term (after 3 months) and long-term (at the end of 6 months ) to analyze the impact of an online wellness program QoL and related outcomes among people with CIS and MS, fibromyalgia, post acute sequela of covid, and cancer in remission wiht persisting fatigue.

The study will use a 7-day window to collect baseline assessments. Participants will use a personal email that does not contain identifying information to participate in the study. Participants will be asked to complete all baseline assessments. This email and password will be used for access to the online course materials. Patients will be randomized to the intervention arm based upon the baseline modified fatigue impact score.

Patients will receive access to the online program and 7 group support videos (released one per week or 7 weeks total). Participants will access the course materials using the study assigned email.

The proposed study will consist of virtual-only participants and will have 3 virtual visits every 3 months (months 0, 3, and 6). Online questionnaires will be sent to the participants to assess fatigue and quality of life. Dietary assessments will include a questionnaire through a web-based tool after baseline, at month 3, and month 6.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

400

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

    • Iowa
      • Iowa City, Iowa, Yhdysvallat, 52246
        • Univeristy of Iowa

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

18 vuotta - 100 vuotta (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • self-reported multiple sclerosis
  • self-reported clinically isolated syndrome

OR self-reported post-acute sequelae of COVID (PASC), also known as long COVID, with a confirmed laboratory test of COVID-19 infection, persisting fatigue and neuropsychiatric symptoms for longer than 6 months after confirmation of COVID diagnosis,

OR self-reported diagnosis of fibromyalgia as documented by their treating specialist or primary care provider,

Exclusion Criteria:

-

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Tukevaa hoitoa
  • Jako: Satunnaistettu
  • Inventiomalli: Crossover-tehtävä
  • Naamiointi: Yksittäinen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Intervention Autoimmune Intervention Mastery Course (AIM) online course

This arm will begin the intervention immediately after randomization

Immediate access to an on line audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care

Muut nimet:
  • AIM-kurssi

Immediate access to videos answering common questions about the course concepts. One video released each week, 7 videos total.

Muut nimet:
  • AIM Q- ja A -istunnot
Muut: Delayed Autoimmune Intervention Mastery Course

This is the control arm.

Delayed access to an on line audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care

Delayed access to videos answering common questions about the course concepts. One video released each week, 7 videos total.

Muut nimet:
  • Viivästynyt AIM Q- ja A-istunto

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Multiple Sclerosis 54 Quality of Life Mental Health (MS 54 QoL MH)
Aikaikkuna: baseline to 3 months

Change in (MS 54 QoL MH) survey questions mean scores, range 0-100, higher number is better.

baseline to 3 months
Multiple Sclerosis 54 Quality of Life Mental Health (MS 54 QoL MH)
Aikaikkuna: baseline to 6months

Change in (MS 54 QoL MH) survey questions mean scores, range 0-100, higher number is better.

baseline to 6months
Multiple Sclerosis 54 Quality of Life Physical Health (MS 54 QoL PH)
Aikaikkuna: baseline to 3 months

Change in (MS 54 QoL PH) survey questions mean scores, range 0-100, higher number is better.

baseline to 3 months
Multiple Sclerosis 54 Quality of Life Physical Health (MS 54 QoL PH)
Aikaikkuna: baseline to 6 months

Change in (MS 54 QoL PH) survey questions mean scores, range 0-100, higher number is better.

baseline to 6 months
Short form 36 (SF 36)
Aikaikkuna: baseline to 3 months

Change in (SF 36) survey questions mean scores, range 0-100, higher number is better.

baseline to 3 months
Short form 36 (SF 36)
Aikaikkuna: baseline to 6 months

Change in (SF 36) survey questions mean scores, range 0-100, higher number is better.

baseline to 6 months
The Functional Assessment of Chronic Illness Therapy - Fatigue Scale (FACIT-FS):
Aikaikkuna: baseline to 3 months

FACIT-FS is a 13-item measure that assesses self-reported fatigue and its impact upon daily activities and function, which can be completed in less than 5 minutes.10 Each question provides 5 ordinal response options ("not at all," "a little bit," "somewhat," "quite a bit," and "very much"). Each item contributes equally (item score range=0-4) to a total score that ranges from 0 to 52, where higher scores represent less fatigue.

baseline to 3 months
The Functional Assessment of Chronic Illness Therapy - Fatigue Scale (FACIT-FS):
Aikaikkuna: baseline to 6 months

FACIT-FS is a 13-item measure that assesses self-reported fatigue and its impact upon daily activities and function, which can be completed in less than 5 minutes.10 Each question provides 5 ordinal response options ("not at all," "a little bit," "somewhat," "quite a bit," and "very much"). Each item contributes equally (item score range=0-4) to a total score that ranges from 0 to 52, where higher scores represent less fatigue.

baseline to 6 months

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Modified Fatigue Impact Scale
Aikaikkuna: baseline to 3 months

Change in MFIS survey questions, scores range from 0-84, lower score is better.

baseline to 3 months
Modified Fatigue Impact Scale
Aikaikkuna: baseline to 6 months

Change in MFIS survey questions, scores range from 0-84, lower score is better.

baseline to 6 months
vegetable and fruit intake
Aikaikkuna: baseline to 3 months

Change in number of servings of vegetables consumed per day, servings range from 0 to 9 or more

baseline to 3 months
vegetable and fruit intake
Aikaikkuna: baseline to 6 months

Change in number of servings of vegetables consumed per day, servings range from 0 to 9 or more

baseline to 6 months
added sugar intake
Aikaikkuna: baseline to 3 months

change in the grams of added sugar consumed each day, grams range from 0 to 100

baseline to 3 months
added sugar intake
Aikaikkuna: baseline to 6 months

change in the grams of added sugar consumed each day, grams range from 0 to 100

baseline to 6 months
calcium intake
Aikaikkuna: baseline to 3 months

change in calcium intake, range 0 to 2000 mg

baseline to 3 months
calcium intake
Aikaikkuna: baseline to 6 months

change in calcium intake, range 0 to 2000 mg

baseline to 6 months
Servings of whole grains consumed
Aikaikkuna: baseline to 3 months

change in number of servings of whole grains consumed, range 0 to 6 or more servings

baseline to 3 months
Servings of whole grains consumed
Aikaikkuna: baseline to 6 months

change in number of servings of whole grains consumed, range 0 to 6 or more servings

baseline to 6 months
Fibromyalgia Impact Questionnaire Revised
Aikaikkuna: baseline to 3 months

Pain Rating (0-10 Low to High Scale) survey questions with higher score indicating greater impact

baseline to 3 months
Fibromyalgia Impact Questionnaire Revised
Aikaikkuna: baseline to 6 months

Pain Rating (0-10 Low to High Scale) survey with 15 items with higher score indicating greater impact

baseline to 6 months
Brief Pain Inventory
Aikaikkuna: baseline to 3 months

Interference (0-10 Low to High Scale) 15 survey items with higher score indicating greater intensity

baseline to 3 months
Brief Pain Inventory
Aikaikkuna: baseline to 6 months

Range 0-10(Low to High Scale) survey with higher score indicating greater pain intensity

baseline to 6 months
FM Disease activity (FIQR)
Aikaikkuna: baseline to 3 months

0-100( Low to High Scale)21 survey items used to evaluate function, overall impact, and symptoms in patients with fibromyalgia.

baseline to 3 months
FM Disease activity (FIQR)
Aikaikkuna: baseline to 6 months

0-100 (Low to High Scale)21 survey items used to evaluate function, overall impact, and symptoms in patients with fibromyalgia. High score indicating more severe symptoms.

baseline to 6 months
Pain scale
Aikaikkuna: baseline to 3 months

0-10 (low to high) 13 survey items used to evaluate feelings about pain.

baseline to 3 months
Pain catastrophizing scale
Aikaikkuna: baseline to 6 months

052 (low to high) 13 survey items used to evaluate feelings about pain. Higher scores indicating more severe feelings about pain related problems

baseline to 6 months
Functional Assessment of Cancer Therapy - General (FACT-G)
Aikaikkuna: baseline to 3 months

measures health-related QoL covering 5 domains: physical well-being (7 items), family/social well-being (7 items), emotional well-being (6 items), functional well-being (7 items), and fatigue-specific items (13 items).10 These items are scored on a 5-point Likert scale, where 0 = "not at all" and 5 = "very much," with a recall period over the past 7 days. Domain scores can be calculated by summing the scores for each domain, and/or a total score by summing the scores for all domains, with higher scores representing better functioning. General guidelines estimate for the FACT-G minimally important difference (MID), is 4-7 points. The total score ranges from 0-108.

baseline to 3 months
Functional Assessment of Cancer Therapy - General (FACT-G)
Aikaikkuna: baseline to 6 months

measures health-related QoL covering 5 domains: physical well-being (7 items), family/social well-being (7 items), emotional well-being (6 items), functional well-being (7 items), and fatigue-specific items (13 items).10 These items are scored on a 5-point Likert scale, where 0 = "not at all" and 5 = "very much," with a recall period over the past 7 days. Domain scores can be calculated by summing the scores for each domain, and/or a total score by summing the scores for all domains, with higher scores representing better functioning. General guidelines estimate for the FACT-G minimally important difference (MID), is 4-7 points. The total score ranges from 0-108.

baseline to 6 months
Optional interview at study conclusion
Aikaikkuna: collected at study conclusion

Asking open ended questions about the participant's study experience, barriers, challenges, web-based aspect of course, social support, geographic location, experience with specific modules and suggestions for improvement for the course and the study

collected at study conclusion

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Sponsori

Tutkijat

  • Päätutkija: Terry L Wahls, MD, University of Iowa

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Yleiset julkaisut

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Keskiviikko 1. joulukuuta 2021

Ensisijainen valmistuminen (Arvioitu)

Keskiviikko 1. joulukuuta 2027

Opintojen valmistuminen (Arvioitu)

Keskiviikko 1. joulukuuta 2027

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Keskiviikko 15. syyskuuta 2021

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Keskiviikko 15. syyskuuta 2021

Ensimmäinen Lähetetty (Todellinen)

Maanantai 27. syyskuuta 2021

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Perjantai 18. syyskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Tiistai 15. syyskuuta 2026

Viimeksi vahvistettu

Lauantai 1. elokuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

JOO

IPD-suunnitelman kuvaus

Will share study data to scientists with a published PROSPERO registered meta-analysis.

IPD-jaon aikakehys

A year after the data has been published.

IPD-jaon käyttöoikeuskriteerit

Scientists with a published (in a peer reviewed journal) PROSPERO meta-analysis protocol who have contacted the PI with a copy of the published protocol, their address, phone number and specific data that is being requested. The PI will review the documents and if determined appropriate, the PI will then initiate an outgoing material data use agreement with the Division of Sponsored Programs at the University of Iowa who will then contact the requesting scientist. Once the date use agreement has been signed, the data will be shared according to the terms outlined in the data use agreement.

IPD-jakamista tukeva tietotyyppi

  • STUDY_PROTOCOL
  • ICF

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa